noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

H-E-B LP

H-E-B and San Antonio Spurs tip-off season with new commercial
Barbara Ann Karmanos Cancer Institute

IN THE NEWS: Understanding Non-Small Cell Lung Cancer
U.S. Department of State

Senior Official Lewin at the G7 Development Minister’s Meeting

Healthcare

Genentech Inc.

10/17/2025 | Press release | Distributed by Public on 10/17/2025 14:30

Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Genentech Inc. published this content on October 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 17, 2025 at 20:30 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back